journal article·2022-11Open access

Large Oncosome‐Loaded VAPA Promotes Bone‐Tropic Metastasis of Hepatocellular Carcinoma Via Formation of Osteoclastic Pre‐Metastatic Niche

Shuxia Zhang, Xinyi Liao, Suwen Chen, Wanying Qian, Man Li, Yingru Xu, Meisongzhu Yang, Xincheng Li, Shuang Mo, Miaoling Tang, Xingui Wu, Yameng Hu, Ziwen Li, Ruyuan Yu, Ainiwaerjiang Abudourousuli, Libing Song, Jun Li

Advanced Science· Volume 9· Issue 31

Abstract

Abstract Tumor‐derived extracellular vesicles (EVs) function as critical mediators in selective modulation of the microenvironment of distant organs to generate a pre‐metastatic niche that facilitates organotropic metastasis. Identifying the organ‐specific molecular determinants of EVs can develop potential anti‐metastatic therapeutic targets. In the current study, large oncosomes (LOs), atypically large cancer‐derived EVs, are found to play a crucial role in facilitating bone‐tropic metastasis of hepatocellular carcinoma (HCC) cells by engineering an osteoclastic pre‐metastatic niche and establishing a vicious cycle between the osteoclasts and HCC cells. Transmembrane protein, VAMP‐associated protein A (VAPA), is significantly enriched on LOs surface via direct interaction with LOs marker αV‐integrin. VAPA‐enriched LOs‐induced pre‐metastatic education transforms the bone into a fertile milieu, which supports the growth of metastatic HCC cells. Mechanically, LOs‐delivered VAPA integrates to plasma membrane of osteoclasts and directly interacts with and activates neural Wiskott–Aldrich syndrome protein (N‐WASP) via dual mechanisms, consequently resulting in ARP2/3 complex‐mediated reorganization of actin cytoskeleton in osteoclasts and osteoclastogenesis. Importantly, treatment with N‐WASP inhibitor 187‐1‐packaged LOs (LOs/187‐1) dramatically abolishes the inductive effect of VAPA‐enriched LOs on pre‐metastatic niche formation and precludes HCC bone metastasis. These findings reveal a plausible mechanism for bone‐tropism of HCC and can represent a potential strategy to prevent HCC bone metastasis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · Extracellular vesicles in disease · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Program of Cancer Research Key Laboratory of Protein Modification and Degradation and Guangzhou Institute of Oncology Affiliated Guangzhou Women and Children's Hospital School of Basic Medical Sciences Guangzhou Medical University Guangzhou 510623 P. R. China

Department of Biochemistry Zhongshan School of Medicine Sun Yat‐sen University Guangzhou 510080 P. R. China

State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou 510080 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (59)

Show source-provided references
1. 10.1002/(SICI)1096-9926(199910)60:4<226::AID-TERA7>3.0.CO;2-W10.1002/(SICI)1096-9926(199910)60:4<226::AID-TERA7>3.0.CO;2-W ↗
2. 10.1016/j.tcb.2020.05.00310.1016/j.tcb.2020.05.003 ↗
3. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
4. 10.3390/cells807072710.3390/cells8070727 ↗
5. 10.1016/j.semcdb.2015.02.01010.1016/j.semcdb.2015.02.010 ↗
6. 10.1186/s13046-019-1317-610.1186/s13046-019-1317-6 ↗
7. 10.1016/j.ajpath.2012.07.03010.1016/j.ajpath.2012.07.030 ↗
8. 10.1158/0008-5472.CAN-16-294210.1158/0008-5472.CAN-16-2942 ↗
9. 10.1038/s41392-020-0134-x10.1038/s41392-020-0134-x ↗
10. 10.3389/fcell.2021.73362710.3389/fcell.2021.733627 ↗
11. 10.1038/nrc305510.1038/nrc3055 ↗
12. 10.1002/advs.20200196110.1002/advs.202001961 ↗
13. 10.1007/s10555-013-9454-410.1007/s10555-013-9454-4 ↗
14. 10.1002/hep.3167310.1002/hep.31673 ↗
15. 10.1016/j.devcel.2019.04.01110.1016/j.devcel.2019.04.011 ↗
16. 10.3390/cancers1317438010.3390/cancers13174380 ↗
17. 10.1186/s12964-020-00643-510.1186/s12964-020-00643-5 ↗
18. 10.1007/s00432-002-0396-410.1007/s00432-002-0396-4 ↗
19. 10.1242/jcs.112.21.372310.1242/jcs.112.21.3723 ↗
20. 10.1074/jbc.M80793820010.1074/jbc.M807938200 ↗
21. 10.18632/oncotarget.359810.18632/oncotarget.3598 ↗
22. 10.1016/j.cell.2012.10.00510.1016/j.cell.2012.10.005 ↗
23. 10.1016/j.cell.2013.07.03610.1016/j.cell.2013.07.036 ↗
24. 10.1158/0008-5472.CAN-08-216410.1158/0008-5472.CAN-08-2164 ↗
25. 10.1016/j.canlet.2016.05.00510.1016/j.canlet.2016.05.005 ↗
26. 10.1007/s11010-017-3004-210.1007/s11010-017-3004-2 ↗
27. 10.1242/jcs.09088610.1242/jcs.090886 ↗
28. 10.1016/j.molcel.2008.10.01210.1016/j.molcel.2008.10.012 ↗
29. 10.1073/pnas.110023610810.1073/pnas.1100236108 ↗
30. 10.1038/nrm286710.1038/nrm2867 ↗
31. 10.1126/science.290.5492.80110.1126/science.290.5492.801 ↗
32. 10.1016/S0092-8674(00)80732-110.1016/S0092-8674(00)80732-1 ↗
33. 10.1016/j.molcel.2004.11.05410.1016/j.molcel.2004.11.054 ↗
34. 10.1126/sciadv.abd649510.1126/sciadv.abd6495 ↗
35. 10.1016/j.bioactmat.2022.01.04810.1016/j.bioactmat.2022.01.048 ↗
36. 10.1038/s41526-021-00146-810.1038/s41526-021-00146-8 ↗
37. 10.1155/2015/42174610.1155/2015/421746 ↗
38. 10.2106/00004623-200308000-0001710.2106/00004623-200308000-00017 ↗
39. 10.1038/sj.gt.330229810.1038/sj.gt.3302298 ↗
40. 10.1038/283669a010.1038/283669a0 ↗
41. 10.7150/thno.3709710.7150/thno.37097 ↗
42. 10.1038/gt.2017.810.1038/gt.2017.8 ↗
43. 10.1016/j.cell.2016.01.04310.1016/j.cell.2016.01.043 ↗
44. 10.1084/jem.2019015810.1084/jem.20190158 ↗
45. 10.1038/s41598-017-03460-y10.1038/s41598-017-03460-y ↗
46. 10.1002/jev2.1206810.1002/jev2.12068 ↗
47. 10.1016/j.tcb.2009.07.00510.1016/j.tcb.2009.07.005 ↗
48. 10.1016/j.tig.2013.01.01110.1016/j.tig.2013.01.011 ↗
49. 10.1007/978-94-007-0763-4_410.1007/978-94-007-0763-4_4 ↗
50. 10.1038/nrg112210.1038/nrg1122 ↗
51. 10.1038/ncomms430810.1038/ncomms4308 ↗
52. 10.1111/j.1440-1746.2005.03919.x10.1111/j.1440-1746.2005.03919.x ↗
53. 10.1634/theoncologist.2010-035810.1634/theoncologist.2010-0358 ↗
54. 10.4143/crt.2007.39.3.10410.4143/crt.2007.39.3.104 ↗
55. 10.1111/j.1478-3231.2005.01094.x10.1111/j.1478-3231.2005.01094.x ↗
56. 10.1097/00042737-200109000-0001510.1097/00042737-200109000-00015 ↗
57. 10.1007/s11864-019-0623-810.1007/s11864-019-0623-8 ↗
58. 10.1038/nature1575610.1038/nature15756 ↗
59. 10.1038/s41556-019-0404-410.1038/s41556-019-0404-4 ↗